Apoptosis-targeted therapies for cancer.
Reed
John C
JC
The Burnham Institute, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA. jreed@burnham.org
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D051017:Apoptosis Regulatory Proteins; D006801:Humans; D008562:Membrane Glycoproteins / Q000187:drug effects / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D053221:TNF-Related Apoptosis-Inducing Ligand; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D019014:fas Receptor / Q000187:drug effects / Q000235:genetics / Q000276:immunology / Q000378:metabolism
D051017:Apoptosis Regulatory Proteins; D008562:Membrane Glycoproteins; D019253:Proto-Oncogene Proteins c-bcl-2; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha; D019014:fas Receptor